XML 48 R41.htm IDEA: XBRL DOCUMENT v3.25.2
Commitments and Contingencies - Additional Information (Detail)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 04, 2024
ft²
Apr. 19, 2024
USD ($)
ft²
Aug. 12, 2022
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Milestone
Jun. 30, 2024
USD ($)
Milestone
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
ft²
Dec. 31, 2021
USD ($)
Nov. 21, 2024
USD ($)
May 31, 2015
USD ($)
Other Commitments [Line Items]                          
Non-cancelable purchase obligations related to manufacturing       $ 6,600,000   $ 6,600,000              
Rental expense       100,000 $ 100,000 200,000 $ 200,000            
Lease liabilities       803,000   803,000   $ 954,000          
ROU assets       773,000   $ 773,000   926,000          
Remaining term of office lease           3 years              
Debt outstanding       0   $ 0              
Indemnification obligations amount       0   0              
Contingent liabilities       0   $ 0              
ALS Therapy Development Foundation, Inc. License Agreement [Member]                          
Other Commitments [Line Items]                          
Fee due for milestones achieved                         $ 1,000,000
Number of Milestones Achieved | Milestone           0 0            
Remaining milestone payments for first licensed product       6,000,000.0   $ 6,000,000.0              
Annual License Maintenance Fee               $ 100,000 $ 100,000 $ 100,000 $ 100,000    
ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 500 Million Aggregate Sales [Member]                          
Other Commitments [Line Items]                          
Reaching of aggregate net sales           500,000,000.0              
Amount of one-time milestone payment       15,000,000.0   15,000,000.0              
ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 1 Billion Aggregate Sales [Member]                          
Other Commitments [Line Items]                          
Reaching of aggregate net sales           1,000,000,000.0              
Amount of one-time milestone payment       30,000,000.0   30,000,000.0              
eGenesis, Inc. Collaboration Agreement [Member]                          
Other Commitments [Line Items]                          
Manufacturing expenses offset           100,000              
Lonza Sales AG Inc. License Agreement                          
Other Commitments [Line Items]                          
Royalties paid           0              
Maximum [Member] | ALS Therapy Development Foundation, Inc. License Agreement [Member]                          
Other Commitments [Line Items]                          
Development and regulatory milestone payments       $ 2,500,000   $ 2,500,000              
Irvine, California [Member]                          
Other Commitments [Line Items]                          
Area of office space | ft²   5,817               5,197      
Operating lease, term of contract   38 months                      
Lease expiration date   Jun. 30, 2027 Dec. 31, 2024                    
ROU assets   $ 500,000                      
Burlington, Massachusetts [Member]                          
Other Commitments [Line Items]                          
Area of office space | ft² 6,138                        
Operating lease, term of contract 36 months                        
Lease expiration date Nov. 21, 2027                        
Lease liabilities                       $ 500,000  
ROU assets                       $ 500,000